SCHEMBL6257463

SCHEMBL6257463

CC(C)(CBr)CCCCCCCCCCC(C)(C)CBr

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.42
CPT2 P23786 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10598543 0.89 TSHR (0.42) FFAR1CPT2TDP1
SCHEMBL26632587 0.89 TSHR (0.42) FFAR1CPT2TDP1
SCHEMBL6269223 0.88 FFAR1 (0.33) FFAR1CPT2TDP1
SCHEMBL17798171 0.84
SCHEMBL11279474 0.83 TSHR (0.36)
SCHEMBL9835291 0.81
SCHEMBL9228967 0.79
SCHEMBL6274695 0.76
SCHEMBL1975737 0.73
SCHEMBL8551965 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1572189-A1 METHOD OF LOWERING CRP AND REDUCING SYSTEMIC INFLAMMATION Warner-Lambert Company LLC (US) 2005-09-14 EP disclosed
WO-2004045596-A1 METHOD OF LOWERING CRP AND REDUCING SYSTEMIC INFLAMMATION WARNER-LAMBERT COMPANY LLC (US) 2004-06-03 WO disclosed